Gummy dosage forms comprising gummy compositions for nutritional supplementation, methods for providing nutritional supplementation, and kits comprising gummy compositions for nutritional supplementation are disclosed. Such gummy compositions for nutritional supplementation may provide improved patient compliance relative to non-gummy compositions for nutritional supplementation. These gummy compositions can be used to administer one or more vitamins, minerals, or trace elements.
A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
A61K 31/194 - Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
A61K 31/519 - Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
A61K 31/14 - Quaternary ammonium compounds, e.g. edrophonium, choline
A61K 31/59 - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
A61K 31/215 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
A23G 3/36 - Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition
A23L 33/00 - Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Compositions for nutritional supplementation and methods for administering such compositions are disclosed. These compositions provide greater patient compliance. These compositions can be used to administer one or more vitamins, minerals, or trace elements.
Gummy dosage forms comprising gummy compositions for nutritional supplementation, methods for providing nutritional supplementation, and kits comprising gummy compositions for nutritional supplementation are disclosed. Such gummy compositions for nutritional supplementation may provide improved patient compliance relative to non-gummy compositions for nutritional supplementation. These gummy compositions can be used to administer one or more vitamins, minerals, or trace elements.
A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
A61K 31/194 - Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
A61K 31/519 - Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
A61K 31/14 - Quaternary ammonium compounds, e.g. edrophonium, choline
A61K 31/59 - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
A61K 31/215 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
A23G 3/36 - Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition
A23L 33/00 - Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
Gummy dosage forms comprising gummy compositions for nutritional supplementation, methods for providing nutritional supplementation, and kits comprising gummy compositions for nutritional supplementation are disclosed. Such gummy compositions for nutritional supplementation may provide improved patient compliance relative to non-gummy compositions for nutritional supplementation. These gummy compositions can be used to administer one or more vitamins, minerals, or trace elements.
12, niacin, calcium, iron, magnesium, zinc, and/or copper, and a second composition comprising omega-3 fatty acids such as DHA, to supplement the nutritional needs of individuals within physiologically stressful states.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Dermatological pharmaceutical products for the treatment of dermatoses, burns and wounds, and itch and pain relief; pharmaceutical preparations for treating skin disorders, namely, dermatoses, burns and wounds, and itch and pain relief; pharmaceutical preparations for use in dermatology, namely, dermatoses, burns and wounds, and itch and pain relief.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Dermatological pharmaceutical products for the treatment of dermatoses, burns and wounds, and itch and pain relief; pharmaceutical preparations for treating skin disorders, namely, dermatoses, burns and wounds, and itch and pain relief; pharmaceutical preparations for use in dermatology, namely, dermatoses, burns and wounds, and itch and pain relief.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Dermatological pharmaceutical products for the treatment of dermatoses, burns and wounds, and itch and pain relief; pharmaceutical preparationsfor treating skin disorders, namely, dermatoses, burns and wounds, and itch and pain relief; pharmaceutical preparations for use in dermatology, namely, dermatoses, burns and wounds, and itch and pain relief.
3, vitamin E, iron, magnesium and zinc, and a second composition comprising omega-3 fatty acids such as DHA, to supplement the nutritional needs of individuals within physiologically stressful states.
A61K 31/34 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
3, vitamin E, iron, magnesium and zinc, and methods for using these compositions for nutritional supplementation in subjects undergoing physiologically stressful events, such as, for example and without limitation, pregnancy, lactation or any disease state.
A61K 31/34 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
3, vitamin E, iron, magnesium and zinc, and methods for using these compositions for nutritional supplementation in subjects undergoing physiologically stressful events, such as, for example and without limitation, pregnancy, lactation or any disease state.
A61K 31/34 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide